MTRY NASDAQ
Monterey Bio Acquisition Corporation
1W: +0.0%
1M: -1.4%
3M: -0.1%
1Y: +9.0%
$11.14
Last traded 2023-11-28 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$21M
-81.7% ▼
Total Liabilities
$2M
+487.2% ▲
Shareholders Equity
$20M
-83.1% ▼
Cash & Investments
$146K
-71.5% ▼
Total Debt
$0
+0.0% ▲
Net Debt
-$146K
+71.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| — Assets — | |||
| Cash | $25K | $511K | $146K |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $25K | $511K | $146K |
| Net Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $0 | $419K | $243K |
| Total Current Assets | $25K | $930K | $389K |
| Property, Plant & Equip. | $0 | $0 | $0 |
| Goodwill & Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $116M | $21M |
| Total Non-Current Assets | $0 | $116M | $21M |
| Total Assets | $25K | $117M | $21M |
| — Liabilities — | |||
| Accounts Payable | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $700K |
| Other Current Liabilities | $1K | $286K | $2M |
| Total Current Liabilities | $1K | $286K | $2M |
| Long-Term Debt | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $700K |
| Total Liabilities | $1K | $286K | $2M |
| — Equity — | |||
| Common Stock | $288 | $116M | $21M |
| Retained Earnings | -$1K | -$584K | -$2M |
| Accumulated OCI | $0 | $0 | $0 |
| Total Stockholders Equity | $24K | $117M | $20M |
| Total Liabilities & Equity | $25K | $117M | $21M |
| — Key Metrics — | |||
| Total Debt | $0 | $0 | $0 |
| Net Debt | -$25K | -$511K | -$146K |
| Total Investments | $0 | $0 | $0 |